FDA Inspections Unlikely Following Documented Manufacturing Changes

FDA normally will not inspect the facilities of device companies with an approved PMA that report changes in manufacturing procedures via 30-day notices unless the Center for Devices and Radiological Health "determines that the notice is inadequate," the agency explains in a recent guidance.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight